-
Myriad Genetics is committed to being your partner of choice
Against the backdrop of recent shifts in the genetic testing industry, we would like to take a minute to reiterate […]
-
Genetic insights for more actionable and personalized prostate cancer
-
Prolaris® is advancing prostate cancer care at ASCO GU
-
Prolaris® is Helping Urologists Reimagine Prostate Cancer Care
-
New Study Proves that Prolaris can Determine which Patients Can Safely Avoid ADT
-
New Data Validating the Prolaris® Test to Guide Treatment for Prostate Cancer
-
1 in 6 Men with Prostate Cancer May Have a Hereditary, Disease-Causing Mutation
-
New Treatment Options Available
-
Medicare Expands Coverage for BRACAnalysis CDx in Prostate Cancer
-
A Message from Myriad Regarding COVID-19
-
Once You Establish These Advanced Prostate Cancer Clinics, It's Easy to…
-
Having a Negative MRI Does Not Mean That You Don't Have a Significant Cancer.
-
How Do You Get Experienced Urologists to Engage in the New Norm For Prostate Cancer?
-
When You Bring in a Partner, It’s the Unknown
-
If We Focus on Taking Care of The Patient, Everything Else Will Take Care of Itself
-
Now We Can Look at Patients and Help Determine If They Need Treatment at All